Jens Bjørheim

Jens Bjørheim is a MD PhD with clinical oncology experience and scientific merits within immunology and cancer genetics. He has 10 years of experience from pharmaceutical industry in Headquarter, Nordic and Baltic positions in Pronova Biopharma (BASF), Novartis, Clavis Pharma and AstraZeneca.